{"id":"https://openalex.org/W2067523973","doi":"https://doi.org/10.1016/0278-5846(94)90116-3","title":"Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis","display_name":"Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis","publication_year":1994,"publication_date":"1994-11-01","ids":{"openalex":"https://openalex.org/W2067523973","doi":"https://doi.org/10.1016/0278-5846(94)90116-3","mag":"2067523973","pmid":"https://pubmed.ncbi.nlm.nih.gov/7531355"},"language":"en","primary_location":{"id":"doi:10.1016/0278-5846(94)90116-3","doi":"https://doi.org/10.1016/0278-5846(94)90116-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0278-5846(94)90116-3","pdf_url":null,"source":{"id":"https://openalex.org/S142279999","display_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","issn_l":"0278-5846","issn":["0278-5846","1878-4216"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110419096","display_name":"Guy Chouinard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088756","display_name":"Royal Victoria Hospital","ror":"https://ror.org/00arwy491","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210088756","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4210130461","display_name":"Institut universitaire en sant\u00e9 mentale de Montr\u00e9al","ror":"https://ror.org/02twt6343","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210130461"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Guy Chouinard","raw_affiliation_strings":["Psychiatric Research Centre, Louis-H. Lafontaine Hospital, University of Montreal, Canada","Clinical Psychopharmacology Unit, Allan Memorial Institute, Royal Victoria Hospital, Department of Psychiatry, McGill University, Montreal, Canada","Psychiatric Research Centre, Louis-H. Lafontaine Hospital, University of Montreal, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Research Centre, Louis-H. Lafontaine Hospital, University of Montreal, Canada","institution_ids":["https://openalex.org/I4210130461","https://openalex.org/I70931966"]},{"raw_affiliation_string":"Clinical Psychopharmacology Unit, Allan Memorial Institute, Royal Victoria Hospital, Department of Psychiatry, McGill University, Montreal, Canada","institution_ids":["https://openalex.org/I4210088756","https://openalex.org/I5023651"]},{"raw_affiliation_string":"Psychiatric Research Centre, Louis-H. Lafontaine Hospital, University of Montreal, Montreal, Canada","institution_ids":["https://openalex.org/I4210130461","https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078578855","display_name":"Juana L. Vainer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088756","display_name":"Royal Victoria Hospital","ror":"https://ror.org/00arwy491","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210088756","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Juana L. Vainer","raw_affiliation_strings":["Clinical Psychopharmacology Unit, Allan Memorial Institute, Royal Victoria Hospital, Department of Psychiatry, McGill University, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Unit, Allan Memorial Institute, Royal Victoria Hospital, Department of Psychiatry, McGill University, Montreal, Canada","institution_ids":["https://openalex.org/I4210088756","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019700659","display_name":"Marie\u2013Claire B\u00e9langer","orcid":"https://orcid.org/0000-0001-9170-3913","observed_orcids":["https://orcid.org/0000-0001-9170-3913"]},"institutions":[{"id":"https://openalex.org/I4210088756","display_name":"Royal Victoria Hospital","ror":"https://ror.org/00arwy491","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210088756","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Marie-Claire B\u00e9langer","raw_affiliation_strings":["Clinical Psychopharmacology Unit, Allan Memorial Institute, Royal Victoria Hospital, Department of Psychiatry, McGill University, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Unit, Allan Memorial Institute, Royal Victoria Hospital, Department of Psychiatry, McGill University, Montreal, Canada","institution_ids":["https://openalex.org/I4210088756","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040330949","display_name":"Luc Turnier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130461","display_name":"Institut universitaire en sant\u00e9 mentale de Montr\u00e9al","ror":"https://ror.org/02twt6343","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210130461"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Luc Turnier","raw_affiliation_strings":["Psychiatric Research Centre, Louis-H. Lafontaine Hospital, University of Montreal, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Research Centre, Louis-H. Lafontaine Hospital, University of Montreal, Montreal, Canada","institution_ids":["https://openalex.org/I4210130461","https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113626465","display_name":"Paul Beaudry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088756","display_name":"Royal Victoria Hospital","ror":"https://ror.org/00arwy491","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210088756","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Paul Beaudry","raw_affiliation_strings":["Clinical Psychopharmacology Unit, Allan Memorial Institute, Royal Victoria Hospital, Department of Psychiatry, McGill University, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Unit, Allan Memorial Institute, Royal Victoria Hospital, Department of Psychiatry, McGill University, Montreal, Canada","institution_ids":["https://openalex.org/I4210088756","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045083719","display_name":"Jean-Yves Roy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130461","display_name":"Institut universitaire en sant\u00e9 mentale de Montr\u00e9al","ror":"https://ror.org/02twt6343","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210130461"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jean-Yves Roy","raw_affiliation_strings":["Psychiatric Research Centre, Louis-H. Lafontaine Hospital, University of Montreal, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Research Centre, Louis-H. Lafontaine Hospital, University of Montreal, Montreal, Canada","institution_ids":["https://openalex.org/I4210130461","https://openalex.org/I70931966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101982616","display_name":"Robert James Miller","orcid":"https://orcid.org/0000-0002-7662-6136","observed_orcids":["https://orcid.org/0000-0002-7662-6136"]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Robert Miller","raw_affiliation_strings":["University of Otago Medical School, Dunedin, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Otago Medical School, Dunedin, New Zealand","institution_ids":["https://openalex.org/I80281795"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4380,"currency":"USD","value_usd":4380},"apc_paid":null,"fwci":1.317,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.79908741,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"18","issue":"7","first_page":"1129","last_page":"1141"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9700000286102295},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":1.0},{"id":"https://openalex.org/keywords/treatment-resistant-schizophrenia","display_name":"treatment-resistant schizophrenia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.9660000205039978},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8040000200271606},{"id":"https://openalex.org/keywords/cholinergic-interneurons","display_name":"cholinergic interneurons","score":0.8090000152587891},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.9449999928474426},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-blockade","display_name":"dopamine D2 receptor blockade","score":0.7319999933242798},{"id":"https://openalex.org/keywords/sex-differences-in-treatment-response","display_name":"sex differences in treatment response","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.910632848739624},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8755066394805908},{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.7794171571731567},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.6707763671875},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6294639110565186},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6272178888320923},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.6176660060882568},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4943661689758301},{"id":"https://openalex.org/C2776978879","wikidata":"https://www.wikidata.org/wiki/Q58376","display_name":"Fluphenazine","level":4,"score":0.49051541090011597},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.4874251186847687},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47799721360206604},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4705750346183777},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.4608265161514282},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.45045900344848633},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.39344102144241333},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.33576634526252747},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3348846435546875},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.06883609294891357},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011605","descriptor_name":"Psychoses, Substance-Induced","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011605","descriptor_name":"Psychoses, Substance-Induced","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012727","descriptor_name":"Sex Characteristics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0278-5846(94)90116-3","doi":"https://doi.org/10.1016/0278-5846(94)90116-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0278-5846(94)90116-3","pdf_url":null,"source":{"id":"https://openalex.org/S142279999","display_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","issn_l":"0278-5846","issn":["0278-5846","1878-4216"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","raw_type":"journal-article"},{"id":"pmid:7531355","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7531355","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in neuro-psychopharmacology & biological psychiatry","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W65626576","https://openalex.org/W1503976483","https://openalex.org/W1965897737","https://openalex.org/W1972922860","https://openalex.org/W2011470429","https://openalex.org/W2040538157","https://openalex.org/W2085360366","https://openalex.org/W2154929433","https://openalex.org/W2206208963","https://openalex.org/W2396384744","https://openalex.org/W2405203525","https://openalex.org/W2406978258","https://openalex.org/W4210957923","https://openalex.org/W4248000293","https://openalex.org/W6602633674"],"related_works":["https://openalex.org/W2079976185","https://openalex.org/W2571343189","https://openalex.org/W2030477730","https://openalex.org/W2183617598","https://openalex.org/W2040559929","https://openalex.org/W2409612373","https://openalex.org/W2466477935","https://openalex.org/W2078563000","https://openalex.org/W2034667449","https://openalex.org/W65626576"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}